ClinicalTrials.Veeva

Menu
K

K2 Medical Research | Tampa, FL

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

BHV-7000
SEP-363856
MK-1167-008
Buntanetap
MK-2214
MK-1167
JNJ-64042056
MK-2214-004
Aticaprant

Parent organization

This site is a part of K2 Medical Research

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 9 total trials

A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)

Researchers want to know if the study treatment called MK-2214 works to slow certain changes in the brains of people with Alzheimer's disease (AD). A...

Enrolling
Early Alzheimer's Disease
Biological: MK-2214
Drug: Placebo

The purpose of this study is to assess the effect of JNJ-64042056 on cognitive decline, as measured by Preclinical Alzheimer's disease Cognitive Comp...

Active, not recruiting
Preclinical Alzheimer's Disease
Drug: JNJ-64042056
Drug: Placebo

Researchers want to learn if giving MK-1167 (the study medicine) along with acetylcholinesterase inhibitor (AChEI) therapy can improve symptoms of Al...

Active, not recruiting
Alzheimer Disease
Dementia
Drug: MK-1167
Drug: Placebo

Trial sponsors

Biohaven logo
Merck Sharp & Dohme (MSD) logo
Otsuka logo
A
Janssen (J&J Innovative Medicine) logo
Janssen (J&J Innovative Medicine) logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems